Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
CTNM on Nasdaq
There are no Buy or Sell transactions made by Versant Venture Capital VI, L.P. since 12/22/2023
Holdings reported by Versant Venture Capital VI, L.P. for Contineum Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Class A Common Stock |
376K |
$6.4M |
$17.05 |
Apr 9, 2024 |
Direct |
|
|
| Class A Common Stock |
148K |
$2.53M |
$17.05 |
Apr 9, 2024 |
Indirect |
|
|
| Series B Preferred Stock |
1.74M |
|
|
Apr 9, 2024 |
Direct |
Class B Common Stock |
|
| Series A-1 Preferred Stock |
1.42M |
|
|
Apr 9, 2024 |
Direct |
Class B Common Stock |
|
| Series C Preferred Stock |
710K |
|
|
Apr 9, 2024 |
Indirect |
Class B Common Stock |
|
| Series B Preferred Stock |
435K |
|
|
Apr 9, 2024 |
Indirect |
Class B Common Stock |
|
| Series A Preferred Stock |
9.25K |
|
|
Apr 9, 2024 |
Indirect |
Class B Common Stock |
|
Transactions reported by Versant Venture Capital VI, L.P. for Contineum Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.